InvestorsHub Logo
Followers 66
Posts 1221
Boards Moderated 0
Alias Born 04/02/2020

Re: ombowstring post# 111637

Thursday, 08/27/2020 11:01:07 AM

Thursday, August 27, 2020 11:01:07 AM

Post# of 232954
I’ve already commented previously on the OWS letter so you know where I stand on that subject... as far as a retraction from the WSJ... that’s highly unlikely... With regards to the other issue regarding OWS, I am reluctant to speculate, but I believe this is a misunderstanding of semantics with Dr. Pourhassan... It was my understanding... and, I’m fairly certain a lot of discussion took place on this board regarding CytoDyn being listed on BARDA site a month or two ago... this listing would require filling out paperwork for Corona watch submission to BARDA. This step was required by any company to be considered for funding and logistical support... I don’t want to put words in Nader’s mouth but, I believe he intended to convey that CytoDyn had not applied for a grant with OWS or formally requested their support. As such, there has been nothing for BARDA to turn down... this goes back to my problem with the WSJ “Senior Administrative Official” statements... everything about those comments are inconsistent with where OWS would be in the process with CytoDyn if they were engaged in forward looking discussions IMO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News